Life expectancy for Progressive Supranuclear Palsy (PSP)

Life expectancy for Progressive Supranuclear Palsy (PSP)

The life expectancy for Progressive Supranuclear Palsy (PSP) varies widely depending on the individual and the progression of the disease. PSP is a rare neurodegenerative disorder that affects movement, balance, vision, speech, and cognitive function. While it is a progressive disease with no cure, the course of the disease can vary significantly from person to person.

On average, individuals with PSP live approximately 6 to 10 years after the onset of symptoms. However, some individuals may live much longer, while others may have a shorter life expectancy. Factors such as age at onset, rate of disease progression, and overall health can all play a role in determining life expectancy.

It's important to note that while there is no cure for PSP, there are treatments available that can help manage symptoms and improve quality of life. A healthcare team can work with individuals with PSP and their families to develop a care plan that addresses their specific needs and goals.

Ā 

Check out our post on some treatments for PSP Symptoms:

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • Understanding Atypical Parkinsonism: PSP, MSA, CBD, and DLB

    Understanding Atypical Parkinsonism: PSP, MSA, ...

    Laura Louizos

    When we talk about Parkinsonism, most people immediately think of Parkinson's Disease (PD). However, there exists a group of less common disorders known as atypical parkinsonism, each with its unique...

    Understanding Atypical Parkinsonism: PSP, MSA, ...

    Laura Louizos

    When we talk about Parkinsonism, most people immediately think of Parkinson's Disease (PD). However, there exists a group of less common disorders known as atypical parkinsonism, each with its unique...

  • Introducing "Faces and Voices of Atypical Parkinsonism" by CCF

    Introducing "Faces and Voices of Atypical Parki...

    Laura Louizos

    At the Coleen Cunningham Foundation (CCF), we've embarked on a new journey to bring awareness to the lesser-known side of Parkinsonism - the atypical forms. Our latest campaign, "Faces and...

    Introducing "Faces and Voices of Atypical Parki...

    Laura Louizos

    At the Coleen Cunningham Foundation (CCF), we've embarked on a new journey to bring awareness to the lesser-known side of Parkinsonism - the atypical forms. Our latest campaign, "Faces and...

  • Understanding the Stages of Dementia with Lewy Bodies (DLB)

    Understanding the Stages of Dementia with Lewy ...

    Laura Louizos

    Dementia with Lewy Bodies (DLB) is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, motor symptoms similar to Parkinson's disease, and fluctuating alertness. The progression of DLB can...

    Understanding the Stages of Dementia with Lewy ...

    Laura Louizos

    Dementia with Lewy Bodies (DLB) is a progressive neurodegenerative disorder characterized by cognitive decline, visual hallucinations, motor symptoms similar to Parkinson's disease, and fluctuating alertness. The progression of DLB can...

  • Understanding the Stages of Multiple System Atrophy (MSA)

    Understanding the Stages of Multiple System Atr...

    Laura Louizos

    Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder affecting several brain regions, resulting in symptoms related to movement, autonomic function, and sleep. Here's how the progression of MSA...

    Understanding the Stages of Multiple System Atr...

    Laura Louizos

    Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder affecting several brain regions, resulting in symptoms related to movement, autonomic function, and sleep. Here's how the progression of MSA...

1 of 4